Literature DB >> 8570299

Blunted peripheral chemoreceptor response to hyperoxia in a group of infants with bronchopulmonary dysplasia.

M Katz-Salamon1, B Jonsson, H Lagercrantz.   

Abstract

Infants with BPD often suffer from chronic hypoxia and require supplemental oxygen (O2). This might affect the sensitivity of peripheral chemoreceptors. Therefore, we assessed peripheral chemoreceptor function in 25 infants with bronchopulmonary dysplasia (BPD) of varying severity, using the hyperoxic test. These infants were compared with 35 preterm infants who did not develop BPD. All infants were tested during the 40th week of postconceptional age and their mean postnatal age was 81.5 +/- 16.3 days. Sixty percent (15/25) of the BPD infants lacked a hyperoxic response, while the proportion of nonresponders to O2 among the other groups was 20% (7/35). The intensity of this response was negatively correlated to time spent on a ventilator and positively to time without supplemental oxygen. The intensity of chemoreceptor function was closely related to the severity of BPD; none of the infants with the most severe form of BPD (grade 3) showed a ventilatory response to hyperoxia. Furthermore, infants with BPD needed significantly longer time to increase their saturation than did non-BPD infants (4.7 and 9.3 sec, respectively). We conclude that many infants with BPD, particularly those with the most severe form of the disease, have abnormally functioning peripheral chemoreceptors.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8570299     DOI: 10.1002/ppul.1950200209

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  19 in total

1.  Early motor and mental development in very preterm infants with chronic lung disease.

Authors:  M Katz-Salamon; E M Gerner; B Jonsson; H Lagercrantz
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-07       Impact factor: 5.747

2.  Improved understanding of respiratory control--implications for the treatment of apnoea.

Authors:  H Lagercrantz
Journal:  Eur J Pediatr       Date:  1995       Impact factor: 3.183

3.  Induced recovery of hypoxic phrenic responses in adult rats exposed to hyperoxia for the first month of life.

Authors:  D D Fuller; Z Y Wang; L Ling; E B Olson; G E Bisgard; G S Mitchell
Journal:  J Physiol       Date:  2001-11-01       Impact factor: 5.182

Review 4.  Ventilatory control in infants, children, and adults with bronchopulmonary dysplasia.

Authors:  Melissa L Bates; De-Ann M Pillers; Mari Palta; Emily T Farrell; Marlowe W Eldridge
Journal:  Respir Physiol Neurobiol       Date:  2013-07-22       Impact factor: 1.931

5.  Acute and chronic changes in the control of breathing in a rat model of bronchopulmonary dysplasia.

Authors:  Gary C Mouradian; Santiago Alvarez-Argote; Ryan Gorzek; Gabriel Thuku; Teresa Michkalkiewicz; Margaret T T Wong-Riley; Girija Ganesh Konduri; Matthew R Hodges
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-17       Impact factor: 5.464

6.  Regional and overall ventilation inhomogeneities in preterm and term-born infants.

Authors:  Thomas Riedel; Manuela Kyburz; Philipp Latzin; Cindy Thamrin; Urs Frey
Journal:  Intensive Care Med       Date:  2008-09-23       Impact factor: 17.440

7.  Delayed chemoreceptor responses in infants with apnoea.

Authors:  M Katz-Salamon
Journal:  Arch Dis Child       Date:  2004-03       Impact factor: 3.791

Review 8.  Hypoxic Episodes in Bronchopulmonary Dysplasia.

Authors:  Richard J Martin; Juliann M Di Fiore; Michele C Walsh
Journal:  Clin Perinatol       Date:  2015-12       Impact factor: 3.430

Review 9.  Carotid chemoreceptor "resetting" revisited.

Authors:  John L Carroll; Insook Kim
Journal:  Respir Physiol Neurobiol       Date:  2012-09-13       Impact factor: 1.931

10.  Lung volume, breathing pattern and ventilation inhomogeneity in preterm and term infants.

Authors:  Philipp Latzin; Stefan Roth; Cindy Thamrin; Gerard J Hutten; Isabelle Pramana; Claudia E Kuehni; Carmen Casaulta; Matthias Nelle; Thomas Riedel; Urs Frey
Journal:  PLoS One       Date:  2009-02-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.